Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Distribution of putative SSI risk factors in adults undergoing open reduction and fixation of long bone fracture.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie·2026

Same author

Added value of point-of-care testing for Group A Streptococcus in community pharmacy sore throat pathways: analysis of the Wales Sore Throat Test and Treat service.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026

Same author

Response to Skally et al.Journal of Hospital Infection, 15/05/2026.

The Journal of hospital infection·2026

Same author

Health inequalities in Escherichia coli bacteraemia and associated antibiotic resistance: A national surveillance study, England, 2018/19 to 2023/24.

The Journal of infection·2026

Same author

Maternal Group B <i>Streptococcus</i> Vaccination: A Three-Country European Consortium to Improve Surveillance and Data Readiness.

Clinical epidemiology·2026

Same author

Stigma and depression among heterosexual men and women living with HIV in the UK: Investigating a conceptual framework.

PloS one·2026

Search research articles

Related Experiment Video

Updated: May 11, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Increasing Pneumocystis pneumonia, England, UK, 2000-2010.

Rishma Maini¹, Katherine L Henderson, Elizabeth A Sheridan

¹Health Protection Agency, London, UK.

Emerging Infectious Diseases

|April 30, 2013

Summary

This summary is machine-generated.

Pneumocystis pneumonia diagnoses rose 7% annually in England, particularly in non-HIV patients with transplants or lung disease. This highlights a need to reassess prevention strategies for Pneumocystis pneumonia.

Keywords:

England P. jirovecii pneumonia Pneumocystis jirovecii fungi pneumonia respiratory infections surveillance

More Related Videos

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Experiment Videos

Last Updated: May 11, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Area of Science:

Medical Microbiology
Infectious Diseases
Epidemiology

Background:

Pneumocystis jirovecii pneumonia (PJP) is an opportunistic infection.
An increase in reported PJP cases in England prompted further investigation.
Understanding trends in PJP is crucial for public health.

Purpose of the Study:

To verify the reported increase in PJP cases in England from 2000-2010.
To analyze trends in PJP diagnoses, hospital admissions, and mortality.
To identify changing risk factors for PJP.

Main Methods:

Analysis of national databases for microbiological and clinical PJP diagnoses.
Review of death certifications and hospital admission data.
Comparison of PJP incidence across different patient groups, including HIV status.

Main Results:

Laboratory-confirmed PJP cases in England increased by an average of 7% annually.
PJP-associated death certifications and hospital admissions also showed an increase.
Increased PJP diagnoses were observed in non-HIV patients, especially transplant recipients, those with hematologic malignancies, and individuals with pre-existing lung disease.
PJP infection rates decreased among HIV-positive adults.

Conclusions:

The study confirms a significant rise in PJP diagnoses among individuals not infected with HIV.
Pre-existing lung disease emerged as a new risk factor for PJP.
The findings necessitate a re-evaluation of PJP risk groups and prevention strategies, especially for non-HIV populations.